Cargando…

Itraconazole nanosuspension for oral delivery: Formulation, characterization and in vitro comparison with marketed formulation

BACKGROUND AND THE PURPOSE OF THE STUDY: Itraconazole is a poorly water soluble drug which results in its insufficient bioavailability. The purpose of the present study was to formulate Itraconazole in a nanosuspension to increase the aqueous solubility and to improve its formulation related paramet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakarani, M., Misra, A.K., Patel, J.K., Vaghani, S.S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304368/ https://www.ncbi.nlm.nih.gov/pubmed/22615599

Ejemplares similares

Cyclosporine A-Nanosuspension: Formulation, Characterization and In Vivo Comparison with a Marketed Formulation
por: Nakarani, Mahendra, et al.
Publicado: (2010)

Study on Formulation, in vivo Exposure, and Passive Targeting of Intravenous Itraconazole Nanosuspensions
por: Yuan, Qi, et al.
Publicado: (2019)

Formulation and evaluation of docetaxel nanosuspensions: In-vitro evaluation and cytotoxicity
por: Ibrahim, Mohamed A., et al.
Publicado: (2019)

Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery
por: Wang, Yonglu, et al.
Publicado: (2011)

Design of Novel Nanoemulsion Formulations for Topical Ocular Delivery of Itraconazole: Development, Characterization and In Vitro Bioassay
por: Mehrandish, Saba, et al.
Publicado: (2022)

Formulation Strategies of Nanosuspensions for Various Administration Routes
por: Pınar, Sıla Gülbağ, et al.
Publicado: (2023)

Formulation and delivery of itraconazole to the brain using a nanolipid carrier system
por: Lim, Wei Meng, et al.
Publicado: (2014)

Enhanced Antihypertensive Activity of Candesartan Cilexetil Nanosuspension: Formulation, Characterization and Pharmacodynamic Study
por: Detroja, Chetan, et al.
Publicado: (2011)

Itraconazole Nanosuspensions via Dual Centrifugation Media Milling: Impact of Formulation and Process Parameters on Particle Size and Solid-State Conversion as Well as Storage Stability
por: Willmann, Ann-Cathrin, et al.
Publicado: (2022)

Bioequivalence of Orally Administered Generic, Compounded, and Innovator‐Formulated Itraconazole in Healthy Dogs
por: Mawby, D.I., et al.
Publicado: (2013)

In vitro and in vivo assessment of hydroxypropyl cellulose as functional additive for enabling formulations containing itraconazole
por: Bachmaier, Rafael D., et al.
Publicado: (2021)

Characteristics of Skin Deposition of Itraconazole Solubilized in Cream Formulation
por: Kim, Hyeongmin, et al.
Publicado: (2019)

Formulation and Process Optimization of Rauvolfia serpentina Nanosuspension by HPMC and In Vitro Evaluation of ACE Inhibitory Potential
por: Touqeer, Syeeda Iram, et al.
Publicado: (2022)

Pharmacokinetics and Relative Bioavailability of Orally Administered Innovator‐Formulated Itraconazole Capsules and Solution in Healthy Dogs
por: Hasbach, A.E., et al.
Publicado: (2017)

Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation
por: Jansen, Anouk M E, et al.
Publicado: (2023)

Lyoprotectant Formulation and Optimization of the J-Aggregates Astaxanthin/BSA/Chitosan Nanosuspension
por: Zhao, Yingyuan, et al.
Publicado: (2023)

Investigation of utilization of nanosuspension formulation to enhance exposure of 1,3-dicyclohexylurea in rats: Preparation for PK/PD study via subcutaneous route of nanosuspension drug delivery
por: Chiang, Po-Chang, et al.
Publicado: (2011)

Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability
por: Rahim, Haroon, et al.
Publicado: (2020)

Formulation and Characterization of Ursodeoxycholic Acid Nanosuspension Based on Bottom-Up Technology and Box–Behnken Design Optimization
por: Boscolo, Oriana, et al.
Publicado: (2023)

Formulation Development and in vitro Characterization of Proliposomes for Topical Delivery of Aceclofenac
por: Gupta, Vandana, et al.
Publicado: (2008)

Formulation and Development of Oral Fast-Dissolving Films Loaded with Nanosuspension to Augment Paroxetine Bioavailability: In Vitro Characterization, Ex Vivo Permeation, and Pharmacokinetic Evaluation in Healthy Human Volunteers
por: Elshafeey, Ahmed Hassen, et al.
Publicado: (2021)

Investigation of formulation variables affecting the properties of lamotrigine nanosuspension using fractional factorial design
por: B., Mishra, et al.
Publicado: (2010)

The Impact of Process and Formulation Parameters on the Fabrication of Efavirenz Nanosuspension to Improve Drug Solubility and Dissolution
por: Rashed, Mahtab, et al.
Publicado: (2022)

Study of Formulation and Process Variables for Optimization of Piroxicam Nanosuspension Using 3(2) Factorial Design to Improve Solubility and In Vitro Bioavailability
por: Alhamhoom, Yahya, et al.
Publicado: (2023)

Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design
por: Gajra, Balaram, et al.
Publicado: (2015)

Formulation and in vitro characterization of cefpodoxime proxetil gastroretentive microballoons
por: Sharma, AK., et al.
Publicado: (2011)

Formulating food protein-stabilized indomethacin nanosuspensions into pellets by fluid-bed coating technology: physical characterization, redispersibility, and dissolution
por: He, Wei, et al.
Publicado: (2013)

Production of Itraconazole Nanocrystal-Based Polymeric Film Formulations for Immediate Drug Release
por: Karagianni, Anna, et al.
Publicado: (2020)

Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment
por: Wahlstrom, Jan L, et al.
Publicado: (2007)

Solubility Determination of c-Met Inhibitor in Solvent Mixtures and Mathematical Modeling to Develop Nanosuspension Formulation
por: Ravi, Maharjan, et al.
Publicado: (2021)

Development of Nanosuspension Formulations Compatible with Inkjet Printing for the Convenient and Precise Dispensing of Poorly Soluble Drugs
por: Leung, Dennis H.
Publicado: (2022)

Formulation Development and In Vitro/In Vivo Characterization of Methotrexate-Loaded Nanoemulsion Gel Formulations for Enhanced Topical Delivery
por: Latif, Muhammad Shahid, et al.
Publicado: (2022)

Nanosuspension Technology: Recent Patents on Drug Delivery and their Characterizations
por: Goel, Surya, et al.
Publicado: (2019)

Formulation and In Vitro Evaluation of Oral Capsules from Liquid Herbal Antimalarials Marketed in Ghana
por: Osei-Asare, Christina, et al.
Publicado: (2021)

Evaluating the Suitability of Using Rat Models for Preclinical Efficacy and Side Effects with Inhaled Corticosteroids Nanosuspension Formulations
por: Chiang, Po-Chang, et al.
Publicado: (2010)

Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension
por: Mc Crudden, Maelíosa T.C., et al.
Publicado: (2018)

Microemulsion-based approach for oral delivery of insulin: formulation design and characterization
por: Momoh, Mumuni A., et al.
Publicado: (2020)

Activity and Safety of Inhaled Itraconazole Nanosuspension in a Model Pulmonary Aspergillus fumigatus Infection in Inoculated Young Quails
por: Wlaź, Piotr, et al.
Publicado: (2015)

Development of enteric submicron particle formulation of papain for oral delivery
por: Sharma, Manu, et al.
Publicado: (2011)

Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions
por: Li, Haowen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ihudhbehqmmlo33ki0rp5bs446